Price target
248.400.000.00%
The 10 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 10 analysts giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
PPLPHARMA EPS for the last quarter is −0.70 INR despite the estimation of −0.35 INR. In the next quarter EPS is expected to reach 0.20 INR. Track more of Piramal Pharma Limited financials and stay on top of what is up with the company.
In the next quarter Piramal Pharma Limited revenue is expected to reach 23.35 B INR. Check out Piramal Pharma Limited revenue and earnings and make informed decisions.
According to analysts, PPLPHARMA price target is 248.40 INR with a max estimate of 310.00 INR and a min estimate of 215.00 INR. Check if this forecast comes true in a year, meanwhile watch Piramal Pharma Limited stock price chart and keep track of the current situation with PPLPHARMA news and stock market news.
We've gathered opinions of 10 analysts rating PPLPHARMA stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.